Evogene Ltd. Logo

Evogene Ltd.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Evogene develops computational predictive biology solutions for agriculture, health, and sustainability.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 16:00
Regulatory News Service
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Foreign Filer Report
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 36.5 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 217.6 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 36.5 KB
2025-07-18 01:00
Foreign Filer Report
Other Report or Announcement
English 180.7 KB
2025-07-18 01:00
Proxy Solicitation & Information Statement
Other Report or Announcement
English 36.7 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 173.8 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 36.6 KB
2025-06-18 01:01
Proxy Solicitation & Information Statement
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 708.7 KB
2025-06-18 01:01
Report Publication Announcement
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 36.4 KB
2025-06-18 01:00
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Foreign Filer Report
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 140.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GenSight Biologics S.A. Logo GenSight Biologics S.A. France SIGHT
Gentian Diagnostics ASA Logo Gentian Diagnostics ASA Norway GENT
Genus PLC Logo Genus PLC United Kingdom GNS
Grace Breeding Ltd. Logo Grace Breeding Ltd. Israel GRAC
Group 107 Ltd. Logo Group 107 Ltd. Israel G107
Guard Therapeutics International AB Logo Guard Therapeutics International AB Sweden GUARD
Gubra A/S Logo Gubra A/S Denmark GUBRA
Hadasit Bio Holding Ltd. Logo Hadasit Bio Holding Ltd. Israel HDST-M
Hansa Biopharma Logo Hansa Biopharma Sweden HNSA
HEMOGENYX PHARMACEUTICALS PLC Logo HEMOGENYX PHARMACEUTICALS PLC United Kingdom HEMO